Home/Filings/4/0001104659-18-025620
4//SEC Filing

LI WILLIAM 4

Accession 0001104659-18-025620

CIK 0001509745other

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 4:07 PM ET

Size

5.5 KB

Accession

0001104659-18-025620

Insider Transaction Report

Form 4
Period: 2018-04-18
LI WILLIAM
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-04-18+11,25011,250 total
    Exercise: $7.66Exp: 2028-04-17Common Stock, $0.001 par value per share (11,250 underlying)
Footnotes (1)
  • [F1]The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 12 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one-month anniversary of April 18, 2018, the Vesting Start Date.

Documents

1 file

Issuer

LEAP THERAPEUTICS, INC.

CIK 0001509745

Entity typeother

Related Parties

1
  • filerCIK 0001273806

Filing Metadata

Form type
4
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 4:07 PM ET
Size
5.5 KB